Decrease of intestinal P-glycoprotein activity by 2n-propylquinoline, a new oral treatment for visceral leishmaniasis.

Source:http://linkedlifedata.com/resource/pubmed/id/12810046

Download in:

View as

General Info

PMID
12810046